Biostatics
Biostatics
批准号:
10017941
负责人:
Yimei Li
金额:
$32.95万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-18 至 2020-08-31
关键词:
AddressApplied ResearchBiometryBiostatistics CoreClinical ResearchClinical TrialsCollaborationsConduct Clinical TrialsDataEnrollmentEnsureExperimental DesignsFeasibility StudiesGoalsIn VitroLaboratoriesMethodsModernizationMonitorNeuroblastomaObservational StudyPaperPatient-Focused OutcomesPatientsPlayReportingReproducibility of ResultsResearchResearch DesignResistanceRoleScienceSpecimenStatistical Data InterpretationStatistical MethodsTechniquesTranslational Researchbasecomputerized data processingdata integritydata qualitydatabase designdesignearly phase clinical trialexperienceexperimental analysisexperimental studyhigh riskimprovedimproved outcomein vivolaboratory experimentmembernovelpatient safetyprogramssuccesstranslational study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY/ABSTRACT
The use of modern statistical methods, analytic techniques, data processing and database design is necessary
in translational research in neuroblastoma (NB). The Biostatistics Core of this program project (PPG), which
comprises biostatistical experts in clinical and translational study design and analysis, Dr. Susan Groshen
(Core Director), Dr. Richard Sposto, and Dr. Yimei Li, and an experienced staff, will play the central role in
fulfilling this requirement. The primary responsibility of the Biostatistics Core is to ensure that appropriate and
efficient statistical designs and analyses are employed in the research. To this end, members of the
Biostatistics Core will involve themselves in the design of laboratory experiments and clinical studies
conducted during this program project. The Core will identify, adapt, or develop appropriate statistical design
and analysis methods, will analyze data, produce coherent and complete reports of the results of these
analyzes, and co-author papers reporting these results. In addition, the Biostatistics Core, collaborating with
Core B, will play an important role in developing and conducting clinical trials undertaken based on the results
of Projects 1 through 5, monitoring the safety of patients enrolled on these trials, and ensuring the quality and
integrity of the data collected from these trials. Core C is essential to the overall success of the translational
mandate of this Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative Statistical Analysis for Genome-Wide Data with General Interval-Censored Outcomes of Oral Health in Childhood Cancer Survivors
-
批准号:10532639
-
项目类别:
-
资助金额:$16.23万
-
财政年份:2021
-
负责人:Yimei Li
-
依托单位:
Biostatics
-
批准号:10265477
-
项目类别:
-
资助金额:$31.36万
-
财政年份:2017
-
负责人:Yimei Li
-
依托单位:
海外基金